Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus disease.
Pediatr Transplant
; 21(1)2017 Feb.
Article
in En
| MEDLINE
| ID: mdl-27753183
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
3_ND
/
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Tablets, Enteric-Coated
/
Ganciclovir
/
Kidney Transplantation
/
Cytomegalovirus Infections
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Pediatr Transplant
Year:
2017
Document type:
Article